"&#xa0;\nWritten evidence submitted by the BioIndustry Association (BIA) (RaD0011)&#xa0;About the BIAEstablished in 1989, the BIA exists to encourage and promote a financially sound and thriving bioscience sector within the UK economy and concentrates its efforts on emerging enterprise and the related interests of companies with whom such enterpri\nses trade. The BIA represents innovative healthcare-focused bioscience companies, including over ninety per cent of biotech medicines currently in clinical development in the UK. BIA members are at the forefront of innovative scientific developments target\ning areas of unmet medical need and this innovation will lead to \nbetter outcomes for patients,\n the development of the knowledge economy, and economic growth. \n&#xa0;Summary&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nThe Biomedical Catalyst \n&#xa0;\n&#xa0;\n&#xa0;\n \n \n&#xa0;\n&#xa0;&#xa0;Crowdfunding&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nThe UK public markets&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nAugust 2013\n&#xa0;\n&#xa0;\n&#xa0;\n              \n"